Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 1, 2004, Pages 72-77

  Machtay, Mitchell ^a,b   Rosenthal, David I ^a,c   Chalian, Ara A ^a   Lustig, Robert ^a   Hershock, Diane ^a   Miller, Linda ^a   Weinstein, Gregory S ^a,c   Weber, Randal S ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemoradiotherapy; Reirradiation; Salvage surgery; Toxicity

Indexed keywords

CHEMOTHERAPY; DISEASE CONTROL; PATIENT MONITORING; POPULATION STATISTICS; SURGERY; TOXICITY; TUMORS;

INFUSION; REIRRADIATION; RESIDUAL DISEASES; SURGICAL SALVAGE;

ONCOLOGY;

AMIFOSTINE; ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; RADIOPROTECTIVE AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DERMATITIS; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DYSPHAGIA; FACE EDEMA; FEASIBILITY STUDY; FEMALE; FEVER; FIBROSIS; FISTULA; FOLLOW UP; FRACTIONATION; HEAD AND NECK CANCER; HUMAN; HYPOTENSION; INFECTION; KIDNEY FAILURE; LIVER CELL CARCINOMA; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUTROPENIA; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION PROTECTION; RADIATION RESPONSE; RECURRENT CANCER; SALVAGE THERAPY; SCHOOL CHILD; SCLERODERMA; SOFT TISSUE DISEASE; SPINAL CORD DISEASE; STROKE; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME; TUMOR BIOPSY; VASCULAR DISEASE; VASCULAR NECROSIS; VOMITING;

ADULT; AGED; AMIFOSTINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHILD; CISPLATIN; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; PROSPECTIVE STUDIES; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 14844330896     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.10.056     Document Type: Article

References (24)

1. Parsons J.T., Mendenhall W.M., Stringer S.P., et al. Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx. Int J Radiat Oncol Biol Phys. 32:1995;605-609.
2. Kraus D.H., Pfister D.G., Harrison L.B., et al. Salvage laryngectomy for unsuccessful larynx preservation therapy. Ann Otol Rhinol Laryngol. 104:1995;936-941.
3. Johnasen L.V., Grau C., Overgaard J. Supraglottic carcinoma - Patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients. Int J Radiat Oncol Biol Phys. 53:2002;948-958.
4. Marcial V.A., Hanley J.A., Ydrach A., et al. Tolerance of surgery after radical radiotherapy of carcinoma of the oropharynx. Cancer. 46:1980;1910-1912.
5. Haraf D.J., Weichselbaum R.R., Vokes E.E. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer A potentially curable disease. Ann Oncol. 7:1996;913-918.
6. Brockstein B., Haraf D.J., Stenson K., et al. A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil, and hydroxyurea with G-CSF support for patients with poor prognosis head and neck cancer. Ann Oncol. 11:2000;721-728.
7. Garofalo M.C., Haraf D.J. Reirradiation A potentially curative approach to locally or regionally recurrent head and neck cancer. Curr Opin Oncol. 14:2002;330-333.
8. Spencer S.A., Harris J., Wheeler R.H., et al. RTOG 96-10 Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys. 51:2001;1299-1304.
9. Stevens K.R.J., Britsch A., Moss W.T. High-dose reirradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys. 29:1994;687-698.
10. DeCrevoisier R., Bourhis J., Domenge C., et al. Full-dose reirradiation for unresectable head and neck carcinoma Experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol. 16:1998;3556-3562.
11. Emami B., Bignardi M., Devineni V.R., et al. Re-irradiation of recurrent head and neck cancers. Laryngoscope. 97:1987;85-88.
12. Benchalal M., Bachaud J.M., Francois P., et al. Hyperfractionated reirradiation after salvage surgery in cervico-facial carcinoma (French). Cancer Radiother. 1:1997;68-73.
13. DeCrevoisier R., Domenge C., Wibault P., et al. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer. 91:2001;2071-2076.
14. Amdur R.J., Parsons J.T., Mendenhall W.M., et al. Postoperative irradiation for squamous cell carcinoma of the head and neck An analysis of treatment results and complications. Int J Radiat Oncol Biol Phys. 16:1989;25-36.
15. Laramore G.E., Scott C.B., Al-Saraff M., et al. Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck Report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys. 23:1992;705-713.
16. Peters L.J., Goepfert H., Ang K.K., et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer First report of a prospective randomized trial. Int J Radiat Oncol Biol Phys. 26:1993;3-11.
17. Brizel D.M., Wasserman T.H., Henke M., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 18:2000;3339-3345.
18. Buntzel J., Kuttner K., Frohlich D., et al. Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer. Ann Oncol. 9:1998;505-509.
19. Bourhis J., Lapeyre M., Tortochaux J., et al. Very accelerated versus conventional radiotherapy in HNSCC Results of the GORTEC 94-02 randomized trial. Proceedings of the American Society for Therapeutic Radiology and Oncology (ASTRO), Boston, 2000. [Abstract] Int J Radiat Oncol Biol Phys. 48(Suppl):2000;III.
20. Antonadou D., Pepelassi M., Synodinou M., et al. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head and neck cancer. Int J Radiat Oncol Biol Phys. 52:2002;739-747.
21. Sivan V., Vozenin-Brotons M.C., Tricaud Y., et al. Altered proliferation and differentiation of human epidermis in cases of skin fibrosis after radiotherapy. Int J Radiat Oncol Biol Phys. 53:2002;385-392.
22. Lefaix J.L., Delanian S., Leplast J.J., et al. Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD. Int J Radiat Oncol Biol Phys. 35:1999;305-312.
23. Delanian S., Balla-Mekias S., Lefaix J.L. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol. 17:1999;2383-3290.
24. Chen Y.J., Kuo J.V., Ramsinghani N.S., et al. Intensity modulated radiotherapy for previously irradiated recurrent head and neck cancer. Med Dosim. 27:2002;171-176.